Innovent Biologics, Inc. (1801.HK) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Innovent Biologics, Inc., with annual and quarterly history.
| Metric | 2025 |
|---|---|
| Valuation | |
| P/E Ratio | 142.68x |
| P/B Ratio | 6.12x |
| P/S Ratio | 9.09x |
| Profitability | |
| Gross Margin | 76.7% |
| Operating Margin | 5.6% |
| Net Margin | 6.2% |
| EBITDA Margin | 10.0% |
| Liquidity | |
| Current Ratio | 2.62x |
| Quick Ratio | 2.47x |
| Leverage | |
| Debt/Equity | 0.15x |
YoY = year-over-year change. Source: FMP..